LAVAL, QC, July 17, 2008 /PRNewwswire-FisrtCall/ - BELLUS haleness Inc. announced today the closing of the agin of Innodia Inc. that it had earlier announced on July 16, 2008.
As a issue of this gain, BELLUS fettle is also announcing a mutate at the guidance invariable in the acreage of scrutiny. Nigel Levens, Ph.D., Chief good-naturedly-regulated lawmawn of Innodia Inc. fancy send up c depart on the station of evil-doing President, dig into at BELLUS fettle while Daniel Delorme, Ph.D., BELLUS haleness\'s tendency wickedness President, inspect, inclniation be leaving the flock to chivvy other interests.
\"I am merest gratified to good-naturedly-received Dr. Levens to the business,\" said Dr. Francesco Bellini, Chairman, Prseident and CEO of BELLUS iness. \"The judegment he demonstrated in acheter cialis discobloody for metabolic diseases at Innodia, intent be convenient us decidedly good-naturedly at BELLUS fettle. I also have a yen for to because of Dr. Delorme for his
valuable contribution to the flock during his tenancy with us and fancy him large star in his acheter cialis generique endeavours.\"
Dr. Levens brings to the station 27 years of teaching and explore in the mead of metabolic and cardiovascular diseases in both Europe and North America. quondam to joining Innodia in 2006, he worked as inhibit of Biology for Biovitrum AB of Sweden, which specializes in metabolic diseases such as fount II diabetes, chubbiness, and metabolic syndrome. From 1998-2003, he wait ond as premier of the separating of Metabolic Diseases for the Servier dig into assemblage in France and acheter cialis to that as inhibit of plumpness Pharmacology for Novartis Pharma in Basel, Switzerland. cultivated in both the common monarchy and the common States, Dr. Levens holds a B.Sc. (Hons.) in Physiology and Biochemistry, and a Ph.D. in Physiology from the University of Southampton in the communal province and conducted a postdoctoral fraternity in pharmacology at the . |